M.C. Garel

982 total citations
28 papers, 738 citations indexed

About

M.C. Garel is a scholar working on Cell Biology, Genetics and Physiology. According to data from OpenAlex, M.C. Garel has authored 28 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cell Biology, 17 papers in Genetics and 15 papers in Physiology. Recurrent topics in M.C. Garel's work include Hemoglobin structure and function (18 papers), Hemoglobinopathies and Related Disorders (17 papers) and Erythrocyte Function and Pathophysiology (14 papers). M.C. Garel is often cited by papers focused on Hemoglobin structure and function (18 papers), Hemoglobinopathies and Related Disorders (17 papers) and Erythrocyte Function and Pathophysiology (14 papers). M.C. Garel collaborates with scholars based in France, United States and Senegal. M.C. Garel's co-authors include J. Rosa, Yves Beuzard, Y. Blouquit, Chantal Domenget, N. Arous, Martine Cohen‐Solal, P Rouyer-Fessard, Claude Préhu, Frédéric Galactéros and Paul‐Henri Roméo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M.C. Garel

28 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Garel France 16 390 303 283 263 169 28 738
Jean Rosa France 17 280 0.7× 260 0.9× 271 1.0× 390 1.5× 164 1.0× 52 909
N. Arous France 18 430 1.1× 343 1.1× 208 0.7× 264 1.0× 198 1.2× 60 933
Suzanna Kwong United States 18 416 1.1× 517 1.7× 283 1.0× 265 1.0× 136 0.8× 32 818
R Rosa France 19 178 0.5× 126 0.4× 450 1.6× 407 1.5× 90 0.5× 60 1.0k
Winston F. Moo-Penn United States 18 528 1.4× 569 1.9× 244 0.9× 326 1.2× 224 1.3× 59 956
Lois R. Manning United States 17 178 0.5× 321 1.1× 150 0.5× 293 1.1× 46 0.3× 32 653
M.J. McDonald United States 13 232 0.6× 464 1.5× 260 0.9× 299 1.1× 82 0.5× 26 834
Helen R. Sunshine United States 6 342 0.9× 220 0.7× 245 0.9× 216 0.8× 153 0.9× 6 592
Stephen M. Waugh United States 7 178 0.5× 200 0.7× 523 1.8× 309 1.2× 149 0.9× 8 840
L.W.‐M. Fung United States 15 64 0.2× 169 0.6× 216 0.8× 211 0.8× 38 0.2× 25 458

Countries citing papers authored by M.C. Garel

Since Specialization
Citations

This map shows the geographic impact of M.C. Garel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Garel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Garel more than expected).

Fields of papers citing papers by M.C. Garel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Garel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Garel. The network helps show where M.C. Garel may publish in the future.

Co-authorship network of co-authors of M.C. Garel

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Garel. A scholar is included among the top collaborators of M.C. Garel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Garel. M.C. Garel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trudel, Marie, Nacéra Saadane, M.C. Garel, et al.. (1991). Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.. The EMBO Journal. 10(11). 3157–3165. 102 indexed citations
2.
Calvin, M., Y. Blouquit, M.C. Garel, et al.. (1990). Human bisphosphoglycerate mutase expressed in E coli: purification, characterization and structure studies. Biochimie. 72(5). 337–343. 9 indexed citations
3.
Trudel, Marie, M.C. Garel, Nacéra Saadane, et al.. (1990). Towards a mouse model for sickle cell disease: HB SAD.. PubMed. 32(6). 407–8. 3 indexed citations
4.
Garel, M.C., V. Joulin, M. Calvin, et al.. (1989). Human Bisphosphoglycerate Mutase. Journal of Biological Chemistry. 264(32). 18966–18972. 22 indexed citations
5.
Rouyer-Fessard, P, M.C. Garel, Chantal Domenget, et al.. (1989). A study of membrane protein defects and α hemoglobin chains of red blood cells in human β thalassemia. Journal of Biological Chemistry. 264(32). 19092–19098. 45 indexed citations
6.
Joulin, V., et al.. (1988). Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA. Biochemical and Biophysical Research Communications. 156(2). 874–881. 17 indexed citations
7.
Joulin, V., et al.. (1988). Isolation and characterization of the human 2,3-bisphosphoglycerate mutase gene.. Journal of Biological Chemistry. 263(30). 15785–15790. 19 indexed citations
8.
Joulin, V., Jean Péduzzi, Paul‐Henri Roméo, et al.. (1986). Molecular cloning and sequencing of the human erythrocyte 2,3-bisphosphoglycerate mutase cDNA: revised amino acid sequence.. The EMBO Journal. 5(9). 2275–2283. 43 indexed citations
9.
Craescu, Constantin T., Claire Poyart, Corinne Schaeffer, et al.. (1986). Covalent binding of glutathione to hemoglobin. II. Functional consequences and structural changes reflected in NMR spectra.. Journal of Biological Chemistry. 261(31). 14710–14716. 65 indexed citations
10.
Sébille, Bernard, et al.. (1986). Study of protein reactivity with thiol reagents by anion-exchange high-performance liquid chromatography. Journal of Chromatography A. 359. 461–474. 6 indexed citations
11.
Garel, M.C., et al.. (1986). Contact inhibition within hemoglobin S polymer by thiol reagents. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 874(1). 82–89. 6 indexed citations
12.
Garel, M.C., et al.. (1984). Inhibition of erythrocyte sickling by thiol reagents.. Molecular Pharmacology. 26(3). 559–565. 25 indexed citations
13.
Garel, M.C., et al.. (1979). Hb A1c: a review on its structure, biosynthesis, clinical significance and methods of assay.. PubMed. 30(5). 234–40. 7 indexed citations
14.
Cohen‐Solal, Martine, et al.. (1978). Haemoglobin strasbourg α2β2 23 (B5) Val → Asp Revised structure and functional properties. FEBS Letters. 90(2). 286–288. 5 indexed citations
15.
Thillet, Joëlle, M.C. Garel, Y. Blouquit, et al.. (1977). Functional studies of Hb Malmö β97 (FG4) His → GLN. FEBS Letters. 84(1). 71–73. 5 indexed citations
16.
Garel, M.C., Michel Goossens, Y. Blouquit, et al.. (1976). Hemoglobin Dakar Hb Grady: Demonstration by a new approach to the analysis of the tryptic core region of the α chain and oxygen equilibrium properties. Biochimica et Biophysica Acta (BBA) - Protein Structure. 453(2). 459–471. 9 indexed citations
17.
Garel, M.C., et al.. (1976). Hemoglobin J Cairo: β 65 (E9) Lys → Gln, a new hemoglobin variant discovered in an Egyptian family. Biochimica et Biophysica Acta (BBA) - Protein Structure. 420(1). 97–104. 16 indexed citations
18.
Garel, M.C., et al.. (1975). Hemoglobin Castilla β 32 (B14) Leu → Arg; A new unstable variant producing severe hemolytic disease. FEBS Letters. 58(1-2). 145–148. 18 indexed citations
19.
Garel, M.C., Martine Cohen‐Solal, Y. Blouquit, & J. Rosa. (1974). A method for isolation of abnormal haemoglobins with high oxygen affinity due to a frozen quaternary R‐structure: Application to Hb creteil α2Aα2 (F5) 89 ASN. FEBS Letters. 43(1). 93–96. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026